CMTEEN_Volume2_Issue2_DT

…room where afflicted lab mice are examined to track the effect of their treatments. But the research facility was the most anticipated stop of the tour. Burgess’s lab was packed…

Audited Financials

…information regarding CMT disorders. The Association encourages, promotes and supports research into the cause, treatment and cure of CMT disorders. The Association also facilitates education and support for persons affected…

2021Sanders

…support, public education, promotion of research and ultimately treatments for and the cure of CMT. MAIL IN DONATIONS (USE THE ENCLOSED ENVELOPE), OR, SUBMIT FORM TO: CMTA, PO BOX 105,…

GAN Community Letter 31JAN2022 Final

treatment of giant axonal neuropathy (GAN). The trial is being conducted by the National Institute of Neurological Disorders and Stroke (NINDS) division of the National Institutes of Health (NIH). This…

CELEBRATING 2023

…and committed investments of $5,000,00 in research dedicated to finding effective treatments and ultimately a cure for Charcot-Marie-Tooth disease. Support for Natural History Studies Drives Clinical Trial Readiness: In 2023,…

CMT-and-Genetic-Testing-Why-Is-It-Important

…process, so if a test is available, it can lead to earlier diagnosis. Finally, genetic diagnosis may help direct treatments and similarly can discontinue ineffective treatments and focus on ones…

TMJulia_23

…Accelerate Research (CMTA-STAR), our initiative which is striving to find effective treatments for CMT, we are also doing everything we can at the CMTA to ensure a brighter future for…

Taysha Letter to the GAN Community – 9.19.2023

treatment of giant axonal neuropathy (GAN). This decision follows the receipt of feedback from the United States (U.S.) Food and Drug Administration (FDA) regarding a registrational path for TSHA-120. FDA…

Type1_Research_Developments_6-2020

As part of this multi-pronged approach to identifying novel treatments for demyelinating CMT, the CMTA is supporting several promising therapeutic opportunities in collaboration with more than a dozen key partners:…

Type2_Research_Developments_6-2020

…stem cells to develop assays and test additional libraries of drugs for treatment in CMT2E. ● We are supporting work in Dr. Ron Liem’s lab at Columbia University to screen…